Biovet JSC (LTS:0III) ROCE %: 15.38% (As of Dec. 2016)


What is Biovet JSC ROCE %?

Biovet JSC LTS:0III ROCE % is 15.38% as of Dec. 2016. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biovet JSC's annualized ROCE % for the quarter that ended in Dec. 2016 was 15.38%.

Biovet JSC  (LTS:0III) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biovet JSC ROCE % Related Terms

Biovet JSC ROCE % Historical Data

* Premium members only.

The historical data trend for Biovet JSC's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC ROCE % Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
ROCE %
Get a 7-Day Free Trial 8.86 10.19 14.58 8.78 12.06

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.95 6.64 21.56 4.57 15.38

Biovet JSC ROCE % Calculation

Biovet JSC's annualized ROCE % for the fiscal year that ended in Dec. 2016 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2016 )  (A: Dec. 2015 )(A: Dec. 2016 )
=19.74/( ( (276.144 - 119.907) + (336.286 - 165.037) )/ 2 )
=19.74/( (156.237+171.249)/ 2 )
=19.74/163.743
=12.06 %

Biovet JSC's ROCE % of for the quarter that ended in Dec. 2016 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2016 )  (Q: Sep. 2016 )(Q: Dec. 2016 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2016 )  (Q: Sep. 2016 )(Q: Dec. 2016 )
=26.016/( ( (313.317 - 146.333) + (336.286 - 165.037) )/ 2 )
=26.016/( ( 166.984 + 171.249 )/ 2 )
=26.016/169.1165
=15.38 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2016) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.38% mean?
Biovet JSC (LTS:0III) has a ROCE % of 15.38% as of Dec. 2016.
Is Biovet JSC's ROCE % too high?
Biovet JSC's current ROCE % is 15.38%. The Drug Manufacturers industry median ROCE % is 7.00. Biovet JSC's value of 15.38% is 119.9% above this industry median.
How does Biovet JSC's ROCE % compare to ADMP and AGRX?
Biovet JSC's ROCE % of 15.38% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Biovet JSC's value of 15.38% is 119.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biovet JSC's current ROCE % of 15.38% is 119.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biovet JSC's current ROCE % is 15.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current ROCE % of 15.38%. The current ROCE % is 15.38% and 119.9% above the Drug Manufacturers industry median of 7.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current ROCE % is 15.38% as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.